From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer
Oncology Letters · 19.11.2026 · 33 (1) · 1-14
DOI: 10.3892/ol.2026.15957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 19.11.2026. Verfasst von Zhenglin He und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
He, Z., Tong, H., Kong, W., Su, W., Li, Y., Wang, G., Hu, W., Qian, L., & Liu, L. (2026). From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer. Oncology Letters, 33(1), 1-14. https://doi.org/10.3892/ol.2026.15957
Vancouver
He Z, Tong H, Kong W, Su W, Li Y, Wang G, et al. From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer. Oncology Letters. 2026;33(1):1-14. doi:10.3892/ol.2026.15957
BibTeX
@article{He2026,
author = {He, Zhenglin and Tong, Hai and Kong, Wan and Su, Weiqin and Li, Yufei and Wang, Gensheng and Hu, Wen and Qian, Liang and Liu, Lubin},
title = {From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer},
journal = {Oncology Letters},
year = {2026},
volume = {33},
number = {1},
pages = {1--14},
doi = {10.3892/ol.2026.15957}
}
EUVIMED